title: [Hypoglycemia in patients treated with an external insulin pump].
abstract: Hypoglycemia is a potentially serious complication of insulin therapy. Some insulin-dependent diabetic patients can benefit from continuous subcutaneous insulin infusion therapy (an "insulin pump"), which in most case improves glycemia control and decreases the occurrence of hypoglycemic episodes. However, such events may occur, particularly during initial treatment phases or pregnancy. Severe hypoglycemia is mainly managed by stopping the insulin pump and insuring an adequate carbohydrate intake. Patients with insulin pumps and their entourage should receive specific instruction in the adjustment of pump flow in the presence of dysglycemia-inducing circumstances (illness, physical exertion), as well as in anticipation of high-risk situations, such as motor-vehicle driving.
authors.affiliation: Service de médecine interne, CHUV, 1011 Lausanne. Jean-Christophe.Laurent@chuv.ch
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Laurent
authors.forename: Gerard
authors.initials: G
authors.lastname: Waeber
authors.forename: Juan
authors.initials: J
authors.lastname: Ruiz
authors.forename: Pierre-Nicolas
authors.initials: PN
authors.lastname: Carron
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced* / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects; D007332:Insulin Infusion Systems / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin